Search Results - "Rahmat, Leena"
-
1
Venetoclax in Combination with Decitabine for Relapsed T-Cell Acute Lymphoblastic Leukemia after Allogeneic Hematopoietic Cell Transplant
Published in Case reports in hematology (01-01-2018)“…Long-term disease-free survival in adults with T-cell acute lymphoblastic leukemia (T-ALL) remains poor, particularly after relapse, with few available salvage…”
Get full text
Journal Article -
2
The Use of Natural Health Products Especially Papaya Leaf Extract and Dandelion Root Extract in Previously Untreated Chronic Myelomonocytic Leukemia
Published in Case reports in hematology (01-01-2018)“…Chronic myelomonocytic leukemia (CMML) is a clonal hematopoietic disorder which shares clinical and morphological features of myelodysplastic syndrome and…”
Get full text
Journal Article -
3
A Rare Oncologic Emergency: Spontaneous Tumor Lysis Syndrome in Metastatic Colon Adenocarcinoma
Published in Clinical practice and cases in emergency medicine (14-10-2019)“…Tumor lysis syndrome is an oncologic emergency that can present with variable symptoms and is truly a laboratory-based diagnosis without pathognomonic clinical…”
Get full text
Journal Article -
4
A rare case of hepatosplenic gamma‐delta T‐cell lymphoma and secondary hemophagocytic lymphohistiocytosis
Published in Clinical case reports (01-01-2019)“…Key Clinical Message Hepatosplenic gamma‐delta T‐cell lymphoma with concurrent hemophogocytic lymphohistiocytosis is a rare but well‐recognized clinical…”
Get full text
Journal Article -
5
The first reported case of vincristine‐induced unilateral vocal cord palsy in an adult patient with HIV‐associated Burkitt‐like lymphoma being treated with dose‐escalated R‐EPOCH
Published in Clinical case reports (01-02-2019)“…Key Clinical Message Vincristine‐induced vocal cord palsy (VCP) is a rare but critical complication. Prompt recognition of VCP is imperative…”
Get full text
Journal Article -
6
Gilteritinib is a clinically active FLT3 inhibitor with broad activity against FLT3 kinase domain mutations
Published in Blood advances (11-02-2020)“…Gilteritinib is the first FMS-like tyrosine kinase 3 (FLT3) tyrosine kinase inhibitor (TKI) approved as monotherapy in acute myeloid leukemia with FLT3…”
Get full text
Journal Article -
7
Taking call for a hematology-oncology practice: Experience of two academic centers
Published in Journal of clinical oncology (20-05-2016)“…Abstract only…”
Get full text
Journal Article -
8
Nonmyeloablative, HLA-Mismatched Unrelated Peripheral Blood Transplantation with High-Dose Post-Transplantation Cyclophosphamide
Published in Transplantation and cellular therapy (01-11-2021)“…•Transplantation of peripheral blood stem cells from mismatched unrelated donors is safe and effective.•Rates of engraftment and graft-versus-host disease are…”
Get full text
Journal Article -
9
Nonmyeloablative, HLA-mismatched unrelated peripheral blood transplantation with high-dose posttransplantation cyclophosphamide
Published in Transplantation and cellular therapy (20-08-2021)Get full text
Journal Article -
10
-
11
-
12
A rare case of hepatosplenic gamma-delta T-cell lymphoma and secondary hemophagocytic lymphohistiocytosis
Published in Clinical case reports (01-01-2019)Get full text
Report -
13
-
14